| selegiline / Generic mfg. |
2006-005140-89: A PHASE I, DOUBLE BLIND, PLACEBO CONTROLLED, RANDOMIZED (WITHIN EACH GROUP) STUDY TO EVALUATE THE INTERACTION BETWEEN ORALLY ADMINISTERED TYRAMINE HYDROCHLORIDE AND RASAGILINE MESILATE IN HEALTHY SUBJECTS |
|
|
| Ongoing | 4 | 160 | Europe | Rasagiline 1mg tablet, Rasagiline 2 mg tablet, TVP-1012, Selegiline HCl 5 PCH, Nardil, Selegiline HCl 5 PCH, Nardil | TEVA Pharmaceuticals Industries Ltd | This postmarketing Phase I study is performed in healthy volunteers. The IMP rasagiline 1mg is indicated for the treatment of Parkinson\'s Disease (PD). | | | | |
ChiCTR2100045946: Improved Excessive Daytime Sleepiness with Selegiline in Parkinson’s Disease: An Open Trial |
|
|
| Completed | 4 | 140 | | Selegiline | The Second Affiliated Hospital of Soochow University; The Second Affiliated Hospital of Soochow University, Self-finance | Parkinson's Diseases | | | | |
NCT04586543: Clinical Trial of Selegiline Plus Docetaxel for the Treatment of Metastatic, Castrate-resistant Prostate Adenocarcinoma |
|
|
| Recruiting | 2 | 110 | Europe | Selegiline, Docetaxel | László Mangel, E-Group ICT Software Informatikai Zrt. | Metastatic Castration-resistant Prostate Cancer, Adenocarcinoma of the Prostate | 02/25 | 02/25 | | |
PK-BesT, NCT05938517: Pharmacokinetic Profile of Betahistine With and Without Selegiline in Healthy Volunteers |
|
|
| Completed | 1 | 15 | Europe | Betahistine dihydrochloride, Vasomotal, Selegiline-hydrochloride, Selegiline-neuraxpharm | Ludwig-Maximilians - University of Munich | Ménière's Disease | 10/21 | 10/21 | | |
ChiCTR1800017949: Clinical study for the effect of the combination of Shudipingchan prescription and Monoamine oxidase inhibitor on improving early PD symptoms and delaying the progression of the disease |
|
|
| Not yet recruiting | N/A | 144 | | Selegiline and Shudipingchan granule ;Selegiline and simulant TCM granule | Longhua Hospital Shanghai University of Traditional Chinese Medicine; Longhua Hospital Shanghai University of Traditional Chinese Medicine, Municipal Hospital emerging frontier technology joint research project | Parkinson's disease | | | | |
ChiCTR1800018017: Clinical study for the effect of the combination of Shudipingchan prescription and Monoamine oxidase inhibitor on improving early Parkinson‘s Disease symptoms and delaying the progression of the disease |
|
|
| Not yet recruiting | N/A | 184 | | Selegiline+Shudipingchan granule ;Selegiline+TCM simulant | Longhua Hospital Shanghai University of Traditional Chinese Medicine; Longhua Hospital Shanghai University of Traditional Chinese Medicine, Municipal Hospital emerging frontier technology joint research project | Parkinson's disease | | | | |
ChiCTR1800015331: Dopaminergic Mechanisms of Temporal Working Memory in Parkinson's Disease |
|
|
| Recruiting | N/A | 150 | | levodopa 4 weeks ;pramipexole 4 weeks ;selegiline 4 weeks | Institute of Psychology, Chinese Academy of Sciences; Peking University Third Hospital, National Natural Science Foundation of China | Parkinson's disease | | | | |
ChiCTR2000037828: Clinical study of Wuqinxi combined with selegilan in improving frozen gait of Parkinson's disease |
|
|
| Recruiting | N/A | 120 | | Routine anti PD treatment + stretching training ;Routine anti PD treatment + stretching training + selegiline ;Routine anti PD treatment + Wuqinxi training ;Routine anti PD treatment + Wuqinxi training + selegiline | Union Medical College Affiliated Hospital of Tongji Medical College, Huazhong University of science and technology; Union Medical College Affiliated Hospital of Tongji Medical College, Huazhong University of Science and Technology, Central funding | Parkinson's disease | | | | |
